BLOCKStrain Technology Corp. (TSXV:DNAX) (OTC:BKKSF), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, announced its participation at the upcoming MaRS HealthKick Focus Conference in Toronto on April 4, 2019, where Chief Executive Officer Robert Galarza will present a keynote address.

Mr. Galarza will discuss the role that technology has played in health and wellness and more specifically, the importance of data driven ecosystem to limit disparity and bring cannabis out of the shadows and into the light of modern medicine. He will discuss the challenges that come with bridging a once illicit industry with sophisticated organizations, as well as the unique opportunities that are unfolding for innovators and entrepreneurs to support this evolving industry. From artificial intelligence and augmented reality, to decentralized ledger solutions, Mr. Galarza will discuss the exciting role that data and technology can have in helping the cannabis industry grow in Canada and beyond.


“I’m honoured for the opportunity to address participants – industry leaders and experts in the science, technology and business of cannabis – at the MaRS HealthKick Focus conference,” said Mr Galarza. “BLOCKStrain has been focused on increasing integrity and transparency in the cannabis industry and strongly believe that technological and scientific advances will enable this. We anticipate that our software can play a pivotal role as the industry continues to evolve and move forward.”

The MaRS HealthKick Focus Conference is a gathering of keynotes, panels and lightning talks from industry leaders and experts as they explore what the industry is doing to make new applications a reality.

About BLOCKStrain:
BLOCKStrain has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. BLOCKStrain’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property and also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. BLOCKStrain’s technology is proprietary, immutable and cryptographically secure, thereby establishing a single-source, accurate, validated and permanent account for cannabis strains from ownership to market.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information: BLOCKStrain Technology Corp. Robert Galarza, Chief Executive Officer and Director; Investor Inquiries: Crystal Quast Bullseye Corporate, 1-844-656-3629, Quast@BullseyeCorporate.com; Media Inquiries: Corey Herscu, 416-410-0404, corey@rnmkr.agency

Click here to connect with BLOCKStrain Technology Corp. (TSXV:DNAX) (OTC: BKKSF) for an Investor Presentation. 

Source: www.newswire.ca

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES /

Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less